Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2026-01-02 @ 8:32 AM
Study NCT ID:
NCT06843967
Status:
RECRUITING
Last Update Posted:
2025-11-12
First Post:
2025-02-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-02-19
Start Date Type:
ACTUAL
Primary Completion Date:
2028-08-19
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-08-19
Completion Date Type:
ESTIMATED
First Submit Date:
2025-02-19
First Submit QC Date:
None
Study First Post Date:
2025-02-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-10
Last Update Post Date:
2025-11-12
Last Update Post Date Type:
ESTIMATED